News
Four new articles from the NIH Technology Transfer Community have been published in the most recent edition of les Nouvelles, the Licensing Executive Society’s journal. NIH is not just a funder of science but is a critical catalyst that helps transform bold ideas into treatments that reach patients
The Licensing Executives Society (LES) is hosting a webinar featuring the National Cancer Institute’s (NCI) Andy Burke discussing Yescarta’s® journey from development to licensing. The presentation will address two topics related to licensing efforts of NCI. The first, a case study on the CAR-T
Register to attend a free NIH webinar featuring a licensing opportunity for a first-of-its-kind male contraceptive hormonal gel, Nestorone®/Testosterone (NES/T), co-developed by the NICHD and Population Council through the Contraceptive Clinical Trials Network (CCTN). This topical, daily self
The National Institutes of Health (NIH) engaged RTI International, a nonprofit research institute, to develop new methods for characterizing and measuring the impact of technologies developed by NIH’s Intramural Research Program. The RTI team created models to illustrate how technologies licensed